Trial Profile
A randomised, double-blind, placebo-controlled study assessing the effect of fenofibrate, coenzyme Q10 and their co-administration on ventricular disatolic function in patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Jun 2016
Price :
$35
*
At a glance
- Drugs Fenofibrate (Primary) ; Ubidecarenone
- Indications Left ventricular dysfunction
- Focus Therapeutic Use
- Sponsors Fournier Laboratories Ireland
- 17 Aug 2011 New trial record